Astra Industrial Group · TADAWUL:1212

Astra Industrial — Investor Presentation (2024)

22 slides from Astra Industrial's investor presentation, 2024

  1. Slide 1: Investor Presentation 2024

    2024 Investor Presentation Creating values for our communities Investor Presentation 2024 1

  2. Slide 2: Contents

    Contents Who we are 3 Our sectors Pharmaceuticals 6-9 Specialty chemicals 10-12 Steel 13-15 Financial performance 16-21 Corporate data Head Office: Riyadh, Saudi Arabia Organized: 2006 and listed 2008 Paid-in Capital: 800,000,000 SAR Total Number of Shares Issued: 80,000,000 SAR Ticker Code on Saudi

  3. Slide 3: Who we are

    Who we are Astra Industrial Group “the Group” is a Saudi industrial investment group headquartered in Riyadh with strong industrial footprint across KSA, Middle East, North Africa, India and Germany. The group is focused on creating long-term value to its shareholders by selecting appropriate indust

  4. Slide 4: Where we are

    Where we are +15 +3900 Astra Industrial Group We have companies in the following countries in +40 countries • Saudi Arabia • Morocco • Sudan • Uzbekistan • Germany • UAE • Jordan • Ukraine • Turkey • Oman • China • Syria • Egypt • Qatar • India • Algeria • Iraq • BVI Investor Presentation 2024 4

  5. Slide 5: Financial highlights

    Financial highlights • Revenues 3,062 Milions SAR • Gross Profit 1,342 Milions SAR • Total Net Profit 601 Milions SAR • Total Assets 4,328 Milions SAR • Total Liabilities 1,797 Milions SAR • Total Equity 2,531 Milions SAR Investor Presentation 2024 5

  6. Slide 6: Pharmaceuticals

    Pharmaceuticals Full Year 2024 Revenue With nearly 2,500 employees across the MENA region, 1,454 Millions SAR Tabuk Pharmaceuticals is a leading branded generic pharmaceutical company that is committed to improving the lives of patients. Business share Considered the 2nd largest Pharmaceutical compa

  7. Slide 7: Tabuk Pharmaceuticals

    Tabuk Pharmaceuticals Considered the second largest Saudi Pharmaceutical company in private sector, Tabuk Pharmaceuticals operates with advanced manufacturing facilities to produce a wide range of dosage forms and products; more than 300 registered products, via the most innovative 300+ registered p

  8. Slide 8: Tabuk Pharma in a snapshot

    Tabuk Pharma in a snapshot Sustaining healthy growth across key markets Key markets developments: KSA Continuing the growth momentum driven by organic volume growth capitalizing on current market penetration Tabuk holds the 2nd largest retail market share with 6.4% of the total retail market as of 2

  9. Slide 9: Tabuk Pharma Recent Deals

    Tabuk Pharma Recent Deals Key agreements to enrich our portfolio TABUK and HK inno.N Partner (South Korean) to bring K-CAB®(TEGOPRAZAN used for gastroesophageal reflux disease (GERD)) An innovative medicine to the MENA region Tabuk Pharmaceuticals Announces Exclusive Licensing Partnership with Hanmi

  10. Slide 10: Specialty Chemicals

    Specialty Chemicals Full Year 2024 Revenue 1,047 Milions SAR Business share Founded in 1988, Astrachem Since establishment in 1993, Astra considered a leading company in the Polymers delivered value to 34% field of compounded fertilizers and thermoplastics industry customers. agrochemicals manufactu

  11. Slide 11: Astra Chem

    Astra Chem Astrachem’s deep experience, long heritage and broad dealer network gives it market edge. Astrachem is a leading company in the field of compounded fertilizers and agrochemical. The company manufactures, formulates and markets creating solutions that make a real difference its own product

  12. Slide 12: Astra Polymers

    Astra Polymers Since its inception 1993, Astra Polymers has continuously delivered exceptional value to customers in the thermoplastics industry. A leader in developing and manufacturing compelling polymer solutions that span a Astra Polymers has continuously delivered exceptional value to customers

  13. Slide 13: Steel

    Steel Full Year 2024 Revenue 562 Milions SAR International Building Systems Factory (IBSF) is accredited with ISO 9001,ISO 14001, ISO 45001, and AISC for operational excellence Business share 18% IBSF is a fabricator of high-quality steel, with unique projects constructed in the Kingdom of Saudi Tot

  14. Slide 14: Steel

    Steel International Building Systems Factory (IBSF) (Manufacturing and Contracting) started in 1993 as steel fabricator & erector, since then International Building Systems Factory grew to be one of the leading and reputed EPC organizations that was incorporated with a vision to meet the ever-growin

  15. Slide 15: IBSF

    IBSF Our Satisfied Clints: Investor Presentation 2024 15

  16. Slide 16: Financial Performance Highlights

    2024 Financial Performance Highlights Delivering Value Investor Presentation 2024 16

  17. Slide 17: Performance Highlights 2024

    Performance Highlights 2024 Strong Profitable YTD Growth combined with Healthy Operating cash flow mSAR Revenue 3,062 +8.6% YoY Net Profit from 552.9 +14.2% YoY +0.9pp cont. operations1&2 1,342 Working Gross Profit +13.5% YoY +1.9pp 229 Days +0% vs Dec’23 Capital 814 YTD Operating Cash EBITDA +22.1%

  18. Slide 18: Growth pillars

    Growth pillars YoY% +10.2% +11.6% -1% +22.2% +8.6% Tabuk pharma Healthy organic growth in key markets such as KSA, GCC and Iraq. Growth is driven by expansion of Saudi private market, enhancement of commercial activities, continuing the growth momentum driven by organic volume growth and capitalizin

  19. Slide 19: Sector performance

    Sector performance Robust profitability growth across all segments YoY% +31% +14.8% +6.2% 77.8% +453% +22.1% Tabuk pharma Maintaining stable profitability growth and margin expansion, showing +1.4pp growth in GP vs PY consistently driven by our major markets. This margin enhancement is driven by gro

  20. Slide 20: Consolidated income statement

    Consolidated income statement Steady Topline & Bottom-line Growth mSAR FY'23 FY'24 Revenues 2,820 3,062 Gross Profit Cost of revenues (1,637) (1,720) Steady growth in the consolidated GP % driven Gross profit 1,182 1,342 mainly by Pharma, Steel and Chemicals sectors Gross profit margin 41.9% 43.8% l

  21. Slide 21: Balance sheet and working capital

    Balance sheet and working capital mSAR ** Cash & Cash equivalents FY'23 FY'24 Net Cash in mSAR 1,058 178 Short term investments (Time deposits / Funds 563 668 1,018 Trade Receivables 944 1,121 693 Inventory 716 686 367 Prepayments & Other current assets 150 128 -444 Total Current Assets 3,432 2,781

  22. Slide 22: Thank You

    Thank You Astra Industries Group P.O.Box 1 5 6 0 Riyadh 1 1 4 4 1 KSA Tel.: 0 0 9 6 6 1 1 4 7 5 2 0 0 2 Fax: 0 0 9 6 6 1 1 4 7 5 2 0 0 1 info@aig.sa www.aig.sa

Astra Industrial Group — Investor Presentation (2024) on 6ix